Whole-Genome Sequencing Demonstrates That Fidaxomicin Is Superior to Vancomycin for Preventing Reinfection and Relapse of Infection With Clostridium difficile

Whole-genome sequencing was used to determine whether the reductions in recurrence of Clostridium difficile infection observed with fidaxomicin in pivotal phase 3 trials occurred by preventing relapse of the same infection, by preventing reinfection with a new strain, or by preventing both outcomes....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Eyre, David W., Babakhani, Farah, Griffiths, David, Seddon, Jaime, Del Ojo Elias, Carlos, Gorbach, Sherwood L., Peto, Tim E. A., Crook, Derrick W., Walker, A. Sarah
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3982846/
https://ncbi.nlm.nih.gov/pubmed/24218500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jit598
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak